Zeitschriftenartikel zum Thema „MpMRI“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "MpMRI" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Yu, Michelle, Avinash Maganty, Liam C. Macleod, Jonathan G. Yabes, Mina M. Fam, Jathin Bandari, Alessandro Furlan et al. „Cost implications of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.“ Journal of Clinical Oncology 37, Nr. 7_suppl (01.03.2019): 65. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.65.
Der volle Inhalt der QuelleVan, Jasper, Choongheon Yoon, Justin Glavis-Bloom, Michelle Bardis, Alexander Ushinsky, Daniel S. Chow, Peter Chang et al. „Deep learning hybrid 3D/2D convolutional neural network for prostate MRI recognition.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): e16600-e16600. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e16600.
Der volle Inhalt der QuelleMantica, Guglielmo, Nazareno Suardi, Salvatore Smelzo, Francesco Esperto, Francesco Chierigo, Stefano Tappero, Marco Borghesi et al. „Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation“. Diagnostics 12, Nr. 11 (01.11.2022): 2656. http://dx.doi.org/10.3390/diagnostics12112656.
Der volle Inhalt der QuellePye, Hayley, Hashim Ahmed, Susan Heavey, Urszula Stopka-Farooqui, Edward Johnston, Ralph Schiess, Silke Gillessen, Shonit Punwani, Mark Emberton und Hayley Whitaker. „Evaluation of Proclarix, a prostate cancer risk score, used together with magnetic resonance imaging for the diagnosis of clinically significant prostate cancer.“ Journal of Clinical Oncology 38, Nr. 6_suppl (20.02.2020): 278. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.278.
Der volle Inhalt der QuelleKarzai, Fatima, Ravi Amrit Madan, Adam G. Sowalsky, Marijo Bilusic, Guinevere Chun, Lisa M. Cordes, Scott C. Wilkinson et al. „A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.“ Journal of Clinical Oncology 38, Nr. 6_suppl (20.02.2020): 368. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.368.
Der volle Inhalt der QuelleTimsit, Marc-Olivier, Giulia Baciarello, Christophe Hennequin, Francois Kleinclauss, Marie Laure Bazil, Philippe Bonnard, Segolene Pettre, Blachier Martin und Henri Leleu. „Effectiveness of early diagnosis for prostate cancer based on PSA and multiparametric MRI: A simulation study.“ Journal of Clinical Oncology 39, Nr. 6_suppl (20.02.2021): 224. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.224.
Der volle Inhalt der QuelleSalami, Simpa S., Jeremy B. Kaplan, Srinivas Nallandhighal, Mandeep Takhar, Jeffrey J. Tosoian, Matthew Lee, Junhee Yoon et al. „Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer“. JCO Precision Oncology, Nr. 3 (Dezember 2019): 1–12. http://dx.doi.org/10.1200/po.19.00054.
Der volle Inhalt der QuelleMaganty, Avinash, Michelle Yu, Liam C. Macleod, Jonathan G. Yabes, Mina M. Fam, Jathin Bandari, Robert Turner et al. „Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.“ Journal of Clinical Oncology 37, Nr. 7_suppl (01.03.2019): 125. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.125.
Der volle Inhalt der QuelleKumar, Abhishek, Dominic LaBella, Michael Snider, Scarlett Acklin-Wehnert, Rajan T. Gupta, Joseph Kamel Salama und Matthew J. Boyer. „Impact of pre-treatment MRI capsular involvement and extraprostatic extension on metastasis free and overall survival in localized prostate cancer.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 5097. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.5097.
Der volle Inhalt der QuelleLashay, Alireza, Jafar Gholivandan, Yaghoob Sehri, Amirreza Elahian und Mahyar Ghafari. „Correlation Between mpMRI Staging and Final Surgical Pathology in Prostate Cancer“. Journal of Molecular Biology Research 10, Nr. 1 (31.03.2020): 6. http://dx.doi.org/10.5539/jmbr.v10n1p6.
Der volle Inhalt der QuelleKovac, Evan, Andrei Purysko, J. Stephen Jones, Cristina Magi-Galluzzi, Eric A. Klein und Andrew J. Stephenson. „Utility of prostate multiparametric MRI (mpMRI) for recurrent prostate cancer after radiation therapy and cryotherapy.“ Journal of Clinical Oncology 34, Nr. 2_suppl (10.01.2016): 71. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.71.
Der volle Inhalt der QuelleLourenço, Mario, Pedro Pissarra, Duarte Vieira E Brito, Miguel Eliseu, Joao Pedro Peralta, Arnaldo Figueiredo und Cristina Marques. „Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece“. Archivio Italiano di Urologia e Andrologia 91, Nr. 4 (13.01.2020): 218–23. http://dx.doi.org/10.4081/aiua.2019.4.218.
Der volle Inhalt der QuelleGrey, Alistair, Rebecca Scott, Bina Shah, Peter Acher, Sidath Liyanage, Menelaos Pavlou, Rumana Omar et al. „The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): 5008. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.5008.
Der volle Inhalt der QuelleVenkatramani, Vivek, Bruno Nahar, Tulay Koru-Sengul, Nachiketh Soodana-Prakash, Mark L. Gonzalgo, Chad Ritch, Dipen Parekh und Sanoj Punnen. „Screening for aggressive prostate cancer: A single-center experience using the 4Kscore and multiparametric MRI for the detection of Gleason 7 or higher prostate cancer.“ Journal of Clinical Oncology 35, Nr. 6_suppl (20.02.2017): 84. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.84.
Der volle Inhalt der QuelleJager, Auke, Jorg R. Oddens, Arnoud W. Postema, Razvan L. Miclea, Ivo G. Schoots, Peet G. T. A. Nooijen, Hans van der Linden et al. „Is There an Added Value of Quantitative DCE-MRI by Magnetic Resonance Dispersion Imaging for Prostate Cancer Diagnosis?“ Cancers 16, Nr. 13 (01.07.2024): 2431. http://dx.doi.org/10.3390/cancers16132431.
Der volle Inhalt der QuelleJia, Yuzhu, Yibo Ying und Jianju Feng. „Multi-Parameter Magnetic Resonance Imaging Fusion Technology Assists in Bone Diagnosis and Rehabilitation of Prostate Cancer“. Journal of Medical Imaging and Health Informatics 11, Nr. 6 (01.06.2021): 1753–60. http://dx.doi.org/10.1166/jmihi.2021.3700.
Der volle Inhalt der QuelleCantiello, Francesco, Stefano Manno, Giorgio I. Russo, Sebastiano Cimino, Salvatore Privitera, Giuseppe Morgia, Antonio Cicione und Rocco Damiano. „Latest Evidence on the Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Insignificant Prostate Cancer: A Systematic Review“. Anti-Cancer Agents in Medicinal Chemistry 18, Nr. 7 (30.11.2018): 925–30. http://dx.doi.org/10.2174/1871520618666180105105413.
Der volle Inhalt der QuelleSonni, Ida, Sahith Doddipalli, Madhvi Deol, David Ban, Hye Ok Kim, Tristan Grogan, Preeti Ahuja et al. „PSMA PET/CT and mpMRI discrepancies in prostate cancer detection with whole-mount histopathology gold standard.“ Journal of Clinical Oncology 42, Nr. 4_suppl (01.02.2024): 284. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.284.
Der volle Inhalt der QuelleKarakoishin, K., Zh Zholdybay, A. Aynakulova, D. Toleshbaev, Zh Amankulov, Zh Zhakenova, A. Beisen, A. Kabidenov und N. Kashaev. „THE CURRENT ROLE OF MULTIPARAMETRIC MRI IN THE DIAGNOSIS OF PROSTATE CANCER: A LITERATURE REVIEW“. Oncologia i radiologia Kazakhstana 64, Nr. 2 (30.06.2022): 66–72. http://dx.doi.org/10.52532/2521-6414-2022-2-64-66-72.
Der volle Inhalt der QuelleNorris, Joseph M., Lina M. Carmona Echeverria, Benjamin S. Simpson, Rhys Ball, Alex Freeman, Daniel Kelly, Alex Kirkham, Hayley C. Whitaker und Mark Emberton. „Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis“. BMJ Open 10, Nr. 10 (Oktober 2020): e039735. http://dx.doi.org/10.1136/bmjopen-2020-039735.
Der volle Inhalt der QuelleZattoni, Fabio, Silvio Maresca, Fabrizio Dal Moro, Iliana Bednarova, Gianmarco Randazzo, Giovanni Basso, Giuseppe Reitano, Gianluca Giannarini, Chiara Zuiani und Rossano Girometti. „Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool“. Diagnostics 13, Nr. 4 (04.02.2023): 578. http://dx.doi.org/10.3390/diagnostics13040578.
Der volle Inhalt der QuelleSonni, Ida, Ely Felker, Andrew Thomas Lenis, Anthony E. Sisk, Shadfar Bahri, Martin S. Auerbach, Wesley R. Armstrong et al. „Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI in the detection, intra-prostatic localization, and local extension of primary prostate cancer: A single-center imaging study with histopathology gold-standard.“ Journal of Clinical Oncology 39, Nr. 6_suppl (20.02.2021): 193. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.193.
Der volle Inhalt der QuelleBrown, Judy, Masoom A. Haider, Jospeh L. K. Chin, Nauthan Perlis, Nicola Schieda und Andrew Loblaw. „Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline“. Canadian Urological Association Journal 16, Nr. 2 (27.01.2022): 16–23. http://dx.doi.org/10.5489/cuaj.7425.
Der volle Inhalt der QuelleBoesen, Lars, Nis Nørgaard, Vibeke Løgager, Ingegerd Balslev und Henrik S. Thomsen. „Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology“. Acta Radiologica 59, Nr. 3 (05.07.2017): 371–80. http://dx.doi.org/10.1177/0284185117718400.
Der volle Inhalt der QuelleTeixeira Anacleto, Sara, Joana Neves Alberto, Emanuel Carvalho Dias, Pedro Sousa Passos und Mário Cerqueira Alves. „Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?“ Archivio Italiano di Urologia e Andrologia 94, Nr. 1 (28.03.2022): 32–36. http://dx.doi.org/10.4081/aiua.2022.1.32.
Der volle Inhalt der QuellePatel, Kartik Shashikant, Tarun Singh, Kshitij Raghuvanshi, Sameer Sonar und Rajeev Chaudhari. „A comparison study of 68gallium-prostate-specific membrane antigen positron emission tomography-computed tomography and multiparametric magnetic resonance imaging for locoregional staging of prostate cancer“. Urological Science 35, Nr. 1 (März 2024): 36–41. http://dx.doi.org/10.1097/us9.0000000000000002.
Der volle Inhalt der QuellePepe, Pietro, Antonio Garufi, Giandomenico Priolo, Giuseppe Dibenedetto, Michele Salemi, Michele Pennisi, Filippo Fraggetta, Francesco Aragona und Michele Barbera. „Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy“. Archivio Italiano di Urologia e Andrologia 86, Nr. 4 (30.12.2014): 336. http://dx.doi.org/10.4081/aiua.2014.4.336.
Der volle Inhalt der QuellePepe, Pietro, Ludovica Pepe, Maria Tamburo, Giulia Marletta, Michele Pennisi und Filippo Fraggetta. „Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer“. Archivio Italiano di Urologia e Andrologia 94, Nr. 3 (26.09.2022): 274–77. http://dx.doi.org/10.4081/aiua.2022.3.274.
Der volle Inhalt der QuelleOderda, Marco, Giorgio Calleris, Daniele D’Agate, Marco Falcone, Riccardo Faletti, Marco Gatti, Giancarlo Marra, Alessandro Marquis und Paolo Gontero. „Intraoperative 3D-US-mpMRI Elastic Fusion Imaging-Guided Robotic Radical Prostatectomy: A Pilot Study“. Current Oncology 30, Nr. 1 (22.12.2022): 110–17. http://dx.doi.org/10.3390/curroncol30010009.
Der volle Inhalt der QuelleValle, Luca Faustino, Jeremie Calais, Leonard S. Marks, Steven Raman, Robert Evan Reiter, Matthew Rettig, John Shen et al. „Radiographic-pathologic concordance in the workup of locally radiorecurrent prostate cancer.“ Journal of Clinical Oncology 41, Nr. 6_suppl (20.02.2023): 313. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.313.
Der volle Inhalt der QuelleKim, Eric, Natalia Miheecheva, Akshaya Ramachandran, Yang Lyu, Ilia Galkin, Viktor Svekolkin, Ekaterina Postovalova et al. „Integrated-omics of MRI-visible and -invisible prostate cancer identifies molecular correlations with clinical outcome.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): e17506-e17506. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e17506.
Der volle Inhalt der QuelleLi, Xinwen, Xiaoyan Wang, Qing Li und Lijie Bai. „CT Combined with Multiparameter MRI in Differentiating Pathological Subtypes of Non-Small-Cell Lung Cancer before Surgery“. Contrast Media & Molecular Imaging 2022 (17.05.2022): 1–7. http://dx.doi.org/10.1155/2022/8207301.
Der volle Inhalt der QuelleParker, Chris, Richard S. Kaplan, Rhian Gabe, Hashim Uddin Ahmed, Khadija Rantell und Mark Emberton. „Multiparametric magnetic resonance imaging in the diagnosis and characterisation of prostate cancer: The PROMIS study.“ Journal of Clinical Oncology 30, Nr. 5_suppl (10.02.2012): 62. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.62.
Der volle Inhalt der QuelleKang, Jae Hoon, Jun-Koo Kang, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Bum Soo Kim, Hyun Tae Kim et al. „Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer“. Journal of Urologic Oncology 21, Nr. 2 (31.07.2023): 112–20. http://dx.doi.org/10.22465/juo.234600160008.
Der volle Inhalt der QuelleTran, Vy, Anne Hong, Tom Sutherland, Kim Taubman, Su-Faye Lee, Daniel Lenaghan, Kapil Sethi et al. „PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer“. BMJ Open 12, Nr. 9 (September 2022): e061815. http://dx.doi.org/10.1136/bmjopen-2022-061815.
Der volle Inhalt der QuelleKlotz, Laurence, Giovanni Lughezzani, Andrrea Sanchez, Frederic Staerman, Hannes Cash, Richard Gaston, Rafael Sanchez-Salas, Eric A. Klein und Gregg Eure. „Comparison of micro-ultrasound and multiparametric MRI imaging for prostate cancer: A multicenter prospective analysis.“ Journal of Clinical Oncology 38, Nr. 6_suppl (20.02.2020): 296. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.296.
Der volle Inhalt der QuelleYamamoto, Takahiro, Hiroaki Okada, Nozomu Matsunaga, Makoto Endo, Toyonori Tsuzuki, Keishi Kajikawa und Kojiro Suzuki. „Clinical characteristics and pathological features of undetectable clinically significant prostate cancer on multiparametric magnetic resonance imaging: A single-center and retrospective study“. Journal of Clinical Imaging Science 14 (19.06.2024): 20. http://dx.doi.org/10.25259/jcis_37_2024.
Der volle Inhalt der QuelleGulin, G. A., A. V. Zyryanov, N. A. Rubtsova, V. M. Artyemov, A. V. Zamyatin und E. A. Grebenev. „Multiparametric magnetic resonance imaging and combined prostate biopsy: opportunities, advantages and pitfalls“. Medical Visualization 25, Nr. 2 (18.05.2021): 138–52. http://dx.doi.org/10.24835/1607-0763-1023.
Der volle Inhalt der QuelleNorris, Joseph M., Veeru Kasivisvanathan, Clare Allen, Rhys Ball, Alex Freeman, Maneesh Ghei, Alex Kirkham, Hayley C. Whitaker, Daniel Kelly und Mark Emberton. „Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol“. Methods and Protocols 3, Nr. 2 (28.03.2020): 26. http://dx.doi.org/10.3390/mps3020026.
Der volle Inhalt der QuelleGuo, Peiying, Longfei Li, Cheng Li, Weijian Huang, Guohua Zhao, Shanshan Wang, Meiyun Wang und Yusong Lin. „Multiparametric Magnetic Resonance Imaging Information Fusion Using Graph Convolutional Network for Glioma Grading“. Journal of Healthcare Engineering 2022 (10.05.2022): 1–11. http://dx.doi.org/10.1155/2022/7315665.
Der volle Inhalt der QuelleLee, Taehyoung, Jen Hoogenes, Ian Wright, Edward D. Matsumoto und Bobby Shayegan. „Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate cancer and its impact on surgical margin status: Experience at a Canadian academic tertiary care centre“. Canadian Urological Association Journal 11, Nr. 5 (09.05.2017): 174. http://dx.doi.org/10.5489/cuaj.4211.
Der volle Inhalt der QuelleMolokwu, Chidi N., Christos Gkikas, Nicola Lee, Joanna Lesniak-Buzon, Faisal Ali und Harry Bardgett. „Abstract P067: Evaluating the risk of clinically significant prostate cancer in lesions detected on multiparametric MRI of the prostate“. Cancer Prevention Research 16, Nr. 1_Supplement (01.01.2023): P067. http://dx.doi.org/10.1158/1940-6215.precprev22-p067.
Der volle Inhalt der QuelleBodar, Yves J. L., Ben G. J. C. Zwezerijnen, Patrick J. van der Voorn, Bernard H. E. Jansen, Ruth S. Smit, Sabrine Q. Kol, Dennie Meijer et al. „Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study“. European Journal of Nuclear Medicine and Molecular Imaging 49, Nr. 5 (02.11.2021): 1731–42. http://dx.doi.org/10.1007/s00259-021-05604-9.
Der volle Inhalt der QuelleVolz, Yannic, Maria Apfelbeck, Nikolaos Pyrgidis, Paulo L. Pfitzinger, Elena Berg, Benedikt Ebner, Benazir Enzinger et al. „The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting“. Diagnostics 13, Nr. 16 (15.08.2023): 2677. http://dx.doi.org/10.3390/diagnostics13162677.
Der volle Inhalt der QuelleMaggi, Martina, Francesco Del Giudice, Ugo G. Falagario, Andrea Cocci, Giorgio Ivan Russo, Marina Di Mauro, Giuseppe Salvatore Sepe et al. „SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study“. Cancers 13, Nr. 9 (23.04.2021): 2047. http://dx.doi.org/10.3390/cancers13092047.
Der volle Inhalt der QuelleHaider, Masoom A., Xiaomei Yao, Andrew Loblaw und Antonio Finelli. „Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline“. Canadian Urological Association Journal 11, Nr. 1-2 (12.01.2017): 1. http://dx.doi.org/10.5489/cuaj.3968.
Der volle Inhalt der QuelleAkin, Oguz, Alfonso Lema-Dopico, Ramesh Paudyal, Amaresha Shridhar Konar, Thomas L. Chenevert, Dariya Malyarenko, Lubomir Hadjiiski et al. „Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies“. Cancers 15, Nr. 22 (18.11.2023): 5468. http://dx.doi.org/10.3390/cancers15225468.
Der volle Inhalt der QuellePepe, Pietro, Marco Roscigno, Ludovica Pepe, Paolo Panella, Marinella Tamburo, Giulia Marletta, Francesco Savoca et al. „Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?“ Journal of Clinical Medicine 11, Nr. 12 (16.06.2022): 3473. http://dx.doi.org/10.3390/jcm11123473.
Der volle Inhalt der QuelleChung, Doo Yong, Min Seok Kim, Jong Soo Lee, Hyeok Jun Goh, Dong Hoon Koh, Won Sik Jang, Chang Hee Hong und Young Deuk Choi. „Clinical Significance of Multiparametric Magnetic Resonance Imaging as a Preoperative Predictor of Oncologic Outcome in Very Low‐Risk Prostate Cancer“. Journal of Clinical Medicine 8, Nr. 4 (19.04.2019): 542. http://dx.doi.org/10.3390/jcm8040542.
Der volle Inhalt der QuellePepe, Pietro, Giuseppe Candiano, Ludovica Pepe, Michele Pennisi und Filippo Fraggetta. „mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: Our experience in 950 cases“. Archivio Italiano di Urologia e Andrologia 93, Nr. 2 (28.06.2021): 139–42. http://dx.doi.org/10.4081/aiua.2021.2.139.
Der volle Inhalt der Quelle